Global Albuterol Sulfate Inhalers Market Size, Share and Trends Analysis Report, by Type (90 mcg, 108 mcg, 120 mcg), and by Application (Kids and Adult), Forecast Period (2022-2028)

The global albuterol sulfate inhalers market is anticipated to grow at a CAGR of 3.7% during the forecast period (2022-2028). Albuterol also known as salbutamol is a prescription medication that is used to prevent and treat wheezing and shortness of breath caused by breathing issues such as asthma, chronic obstructive pulmonary disease. The rise in asthma and COPD incidence is propelling the global albuterol sulfate inhalers market forward. According to the World Health Organization (WHO), asthma afflicted an estimated 262 million people in 2019 and led to 461,000 deaths. Furthermore, an increase in the number of Chronic obstructive pulmonary disease  (COPD) patients contributes to the market’s expansion. In 2018, according to the American Lung Organization 99 million adults in the US had chronic bronchitis, and 2 million adults had emphysema,. According to new research published in The Lancet Respiratory Medicine in 2018, exposure to cigarette smoking, air pollution, chemical fumes or dust, and a rare hereditary disorder are a few of the key variables that contribute to COPD. COPD causes chronic lung damage even before the patient experiences any symptoms.

 

Furthermore, advancements in respiratory disease treatment and new product launches in the global albuterol sulfate inhalers market are expected to boost the market growth. For instance, in January 2019, GlaxoSmithKline plc., announced that Prasco had launched an authorized generic version of GSK’s Ventolin HFA (albuterol) inhalation aerosol. Ventolin HFA is licensed for the treatment or prevention of bronchospasm in reversible obstructive airway disease patients aged 4 years and older, as well as the prevention of exercise-induced bronchospasm in patients aged 4 years and older.

 

Aditionally, the overall business is increasing as the number of initiatives conducted by government and non-government groups increases. The National Asthma Control Program (NACP) of the Centers for Disease Control and Prevention (CDC) offers to fund for asthma education. As a result of such measures, more people will be aware of asthma, which will increase the use of asthma medications, resulting in verticle growth.

 

In addittion, the market is being boosted by the presence of major pharmaceutical companies, modern healthcare infrastructure, and increased research and development activities in the creation of novel medicines. For instance, in July 2020, Teva Pharmaceutical Industries Ltd., has launched ProAir Digihaler (albuterol sulfate 117 mcg) Inhalation Powder, the first and only digital rescue inhaler indicated for the treatment or prevention of bronchospasm in patients four years and older with reversible obstructive airway disease, as well as the prevention of exercise-induced bronchospasm (EIB). Built-in Bluetooth Wireless Technology sensors connect to a companion mobile app and provide information about inhaler events.

 

Market Coverage

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
  • By Type
  • By Indication
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape- GlaxoSmithKline plc., Merck & Co., Inc., Orion Oyj, Teva Pharmaceutical Industries Ltd., among others.

 

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
  • Deviation from the pre-COVID-19 forecast
  • Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

 

Global Albuterol Sulfate Inhalers Market Report by Segment

By Type

• 90 mcg
• 108 mcg
• 120 mcg

By Application

• Kids
• Adult

 

Global Albuterol Sulfate Inhalers Market Report by Region

North America

• US
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa